TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111 | +6.7% | 2,934 | +6.8% | 0.00% | – |
| Q2 2023 | $104 | +55.2% | 2,747 | -0.7% | 0.00% | – |
| Q1 2023 | $67 | -17.3% | 2,766 | -1.4% | 0.00% | – |
| Q4 2022 | $81 | -99.9% | 2,805 | -0.4% | 0.00% | – |
| Q3 2022 | $84,000 | -16.8% | 2,815 | +0.3% | 0.00% | – |
| Q2 2022 | $101,000 | -20.5% | 2,806 | -4.5% | 0.00% | – |
| Q1 2022 | $127,000 | -13.0% | 2,938 | +0.5% | 0.00% | – |
| Q4 2021 | $146,000 | -26.6% | 2,922 | -6.7% | 0.00% | -100.0% |
| Q3 2021 | $199,000 | -17.8% | 3,133 | -6.8% | 0.00% | 0.0% |
| Q2 2021 | $242,000 | -1.6% | 3,360 | +0.8% | 0.00% | 0.0% |
| Q1 2021 | $246,000 | -58.9% | 3,332 | -22.0% | 0.00% | -66.7% |
| Q2 2014 | $599,000 | +25.8% | 4,270 | -0.4% | 0.00% | +50.0% |
| Q1 2014 | $476,000 | +41.7% | 4,287 | +26.2% | 0.00% | 0.0% |
| Q4 2013 | $336,000 | – | 3,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |